One trial involving 60 abdominally obese subjects with reduced GH secretion reported a significant reduction in abdominal fat after 12 months of tesamorelin at up to 2mg/once-daily [24]
Although results may vary by individual, the effects can last several hours, and regular use may support long-term vitality
While some reviews mention delays, the guarantee provides risk-free trial potential
Compounded medications discussed here are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing
Elucidating this issue is complicated by multiple confounding factors, including population heterogeneity, medication use, dietary and lifestyle variations, disease staging, and inconsistencies in research methodologies